首页> 外文期刊>Evolution: International Journal of Organic Evolution >Epistasis buffers the fitness effects of rifampicin- resistance mutations in Pseudomonas aeruginosa
【24h】

Epistasis buffers the fitness effects of rifampicin- resistance mutations in Pseudomonas aeruginosa

机译:上位性缓冲铜绿假单胞菌对利福平耐药突变的适应性作用

获取原文
获取原文并翻译 | 示例
       

摘要

Epistatic interactions between resistance mutations in antibiotic-free environments potentially play a crucial role in the spread of resistance in pathogen populations by determining the fitness cost associated with resistance. We used an experimental evolution approach to test for epistatic interactions between 14 different pairs of rifampicin mutations in the pathogenic bacterium Pseudomonas aeruginosa in 42 different rifampicin-free environments. First, we show that epistasis between rifampicin-resistance mutations tends to be antagonistic: the fitness effect of having two mutations is generally smaller than that predicted from the effects of individual mutations on the wild-type. Second, we show that sign epistasis between resistance mutations is both common and strong; most notably, pairs of deleterious resistance mutations often partially or completely compensate for each others' costs, revealing a novel mechanism for compensatory adaptation. These results suggest that antagonistic epistasis between intragenic resistance mutations may be a key determinant of the cost of antibiotic resistance and compensatory adaptation in pathogen populations.
机译:在不含抗生素的环境中,耐药突变之间的上位相互作用可能通过确定与耐药相关的适应性成本而在病原菌种群中的耐药传播中发挥关键作用。我们使用一种实验性的进化方法来测试在42种不同的无利福平环境中,致病性细菌铜绿假单胞菌中14对不同的利福平突变之间的上位相互作用。首先,我们证明了耐利福平突变之间的上位性趋于拮抗:具有两个突变的适应性效应通常小于根据单个突变对野生型的效应所预测的适应性效应。其次,我们证明了抗药性突变之间的体征上位既常见又很强。最值得注意的是,成对的有害抗性突变通常部分或完全补偿彼此的成本,从而揭示了一种新的补偿适应机制。这些结果表明,基因内耐药性突变之间的拮抗上位性可能是致病菌种群中抗生素耐药性和代偿适应性成本的关键决定因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号